Bone morphogenetic protein-9 is a circulating vascular quiescence factor. - Archive ouverte HAL Access content directly
Journal Articles Circulation Research Year : 2008

Bone morphogenetic protein-9 is a circulating vascular quiescence factor.

(1) , (1) , (1) , (2) , (2) , (3) , (3) , (1) , (1)
1
2
3

Abstract

Angiogenesis is a complex process, requiring a finely tuned balance between numerous stimulatory and inhibitory signals. ALK1 (activin receptor like-kinase 1) is an endothelial-specific type 1 receptor of the transforming growth factor-beta receptor family. Heterozygotes with mutations in the ALK1 gene develop hereditary hemorrhagic telangiectasia type 2 (HHT2). Recently, we reported that bone morphogenetic protein (BMP)9 and BMP10 are specific ligands for ALK1 that potently inhibit microvascular endothelial cell migration and growth. These data lead us to suggest that these factors may play a role in the control of vascular quiescence. To test this hypothesis, we checked their presence in human serum. We found that human serum induced Smad1/5 phosphorylation. To identify the active factor, we tested neutralizing antibodies against BMP members and found that only the anti-BMP9 inhibited serum-induced Smad1/5 phosphorylation. The concentration of circulating BMP9 was found to vary between 2 and 12 ng/mL in sera and plasma from healthy humans, a value well above its EC(50) (50 pg/mL). These data indicated that BMP9 is circulating at a biologically active concentration. We then tested the effects of BMP9 in 2 in vivo angiogenic assays. We found that BMP9 strongly inhibited sprouting angiogenesis in the mouse sponge angiogenesis assay and that BMP9 could inhibit blood circulation in the chicken chorioallantoic membrane assay. Taken together, our results demonstrate that BMP9, circulating under a biologically active form, is a potent antiangiogenic factor that is likely to play a physiological role in the control of adult blood vessel quiescence.

Keywords

Fichier principal
Vignette du fichier
Ms_CIRCRESAHA-2007-165530_.pdf (236.97 Ko) Télécharger le fichier
Vignette du fichier
expanded_materials_and_Methods.doc (62 Ko) Télécharger le fichier
Vignette du fichier
figure_1.ppt (129.5 Ko) Télécharger le fichier
Vignette du fichier
figure_2.ppt (140 Ko) Télécharger le fichier
Vignette du fichier
figure_3_.ppt (209 Ko) Télécharger le fichier
Vignette du fichier
figure_4.ppt (123 Ko) Télécharger le fichier
Vignette du fichier
figure_5.ppt (1.61 Mo) Télécharger le fichier
Vignette du fichier
figure_6.ppt (2.17 Mo) Télécharger le fichier
Vignette du fichier
Figure_legend_for_suppl_figures.doc (33 Ko) Télécharger le fichier
Vignette du fichier
Materials_and_Methods_for_suppl_figures.doc (29 Ko) Télécharger le fichier
Vignette du fichier
supl_figure_2.ppt (6.57 Mo) Télécharger le fichier
Vignette du fichier
suppl._figure_1.ppt (806.5 Ko) Télécharger le fichier
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Format : Other
Loading...

Dates and versions

inserm-00277236 , version 1 (29-08-2008)

Identifiers

Cite

Laurent David, Christine Mallet, Michelle Keramidas, Noël Lamandé, Jean-Marie Gasc, et al.. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.: BMP9 is present in serum and inhibits angiogenesis. Circulation Research, 2008, 102 (8), pp.914-22. ⟨10.1161/CIRCRESAHA.107.165530⟩. ⟨inserm-00277236⟩
434 View
813 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More